Keywords: biogen, 4th-qtr, net, income, climbs, fourth-quarter, biotechnology
Biogen's 4th-qtr net income climbs 85%
Article | 14 February 2008
Fourth-quarter 2007 income at US biotechnology company Biogen Idec was $201.2 million, equivalent to $0.67 per share, up 85.3% on the comparable period last ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
